期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

2014年局部晚期头颈部鳞癌内科治疗进展 被引量：1

2014 Clinical Advances in Locally Advanced Head and Neck Squamous Cell Carcinoma
下载PDF
导出
摘要 头颈部鳞癌（head and neck squamous cell carcinoma,HNSCC）是第6位常见的恶性肿瘤,但大部分患者在就诊时肿瘤已经处于局部晚期。近年来,局部晚期头颈部鳞癌（locally advanced head and neck squamous cell carcinoma,LASCCHN）的治疗方式发生了很大的变化,
作者 郑登云 管吉林
机构地区 广东省人民医院肿瘤中心头颈肿瘤内科广东省医学科学院
出处 《循证医学》 CSCD 2015年第1期14-15,共2页 The Journal of Evidence-Based Medicine
关键词 头颈部鳞癌 治疗进展 临床试验 head and neck squamous cell carcinoma research advance clinical trial
分类号 R739.91 [医药卫生—肿瘤]
  • 相关文献

参考文献7

  • 1Egloff AM, Lee JW, Langer C J, et al. Phase I1 study of Cetuximab in combination with Cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern Cooperative Oncology Group Trial E3303 [J]. Clin Cancer Res, 2014, 20(19): 5041-5051. 被引量：1
  • 2Harari PM, Harris J, Kies M, et al. Postoperative chemoradiothcrapy and Cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234[J]. J Clin Oncol, 2014, 32(23): 2486- 2495. 被引量：1
  • 3Cohen EE, Karrison TG, Kocherginsky Met al. Phase !!I randomized trial of induction chemotherapy in patients with N3 or N3 locally advanced head and neck cancer[J]. J Clin Oncol, 2014, 32(25): 2735-2743. 被引量：1
  • 4Mafia GG. Concomitant chemoradiation (CRT) or Cetuximab/ RT (CET/RT) versus induction Docetaxel/Cisplatin/5- Fluorouracil (TPF) followed by CRT or CET/RT in patients with locally advanced squamous cell carcinoma of head and neck (LASCCHN). A randomized phase III factorial study (NCT01086826) [J]. J Clin Oncol, 2014,32(15s) : Abstr 6004. 被引量：1
  • 5Wanebo HJ, Lee J, Burtness BA, et al. Induction Cetuximab, Paclitaxel, and Carboplatin followed by chemoradiation with Cetuximab, Paclitaxel, and Carboplatin for stage Ill/IV head and neck squamous cancer: A phase II ECOG-ACRIN trial (E2303)[J]. Ann Oncol, 2014, 25(10): 2036-2041. 被引量：1
  • 6Sosa AE, Grau JJ, Feliz L, et al. Outcome of patients treated with palliative weekly Paclitaxel plus Cetuximab in recurrent head and neck cancer after failure of platinum-based therapy[J]. Eur Arc Otorhinolaryngo[, 2014, 271(2): 373-378. 被引量：1
  • 7Vermorken JB, Peyrade F, Krauss J, et al. Cisplatin, 5- Fuorouracil, and Cetuximab (PFE) with or without Cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: Results of the randomized phase I /II ADVANTAGE trim (phase 1/ part)[J]. Ann Oncol, 2014, 25(3): 682-688. 被引量：1

同被引文献10

  • 1廖光东,乔友林.人乳头瘤状病毒检测分型技术进展[J].癌症进展,2007,5(1):48-53. 被引量：8
  • 2Gypsyamber D, Kreimer A R, Raphael V, et al. Case-control study of human papillomavirus and oropharyngeal cancer.[J]. N Engl J Med, 2007,356(19):1944-1956. 被引量：1
  • 3White EA, Kramer RE, Tan MJA, et al. Comprehensive a- nalysis of host cellular interactions with human papillomavir- us E6 proteins identifies new E6 binding partners and reflects viral diversity[J], f Virol, 2012,86(24) : 13174-13186. 被引量：1
  • 4Yu Y, Zhang Y, Zhang S. MicroRNA-92 regulates cervical tumorigenesis and its expression is upregulated by human papillomavirus-16 E6 in cervical cancer cells[J]. Oacol Lett, 2013,6(2) : 468-474. 被引量：1
  • 5Shyu JS, Chen CJ, Chiu CC, et al Correlation of human pap- iltomavirus 16 and 18 with cervical neoplasia in histological typing and clinical stage in Taiwan: an in-situ polymerase chain reaction approach[J]. J Surg Oncol, 2001, 78(2):101- 109. 被引量：1
  • 6Ylitalo N, Josefsson A, Melbye M, et al. A prospective stud- y showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ[ J]. Cancer Res, 2000, 60(21) : 6027-6032. 被引量：1
  • 7Nichols A, Faquin WW, Mroz E, et al. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma[J]. Otolaryn g ol Head Neck Surg , 2009,140 (2): 228-234. 被引量：1
  • 8Worden FP, Bhavna K, Lee JS, et al. Chemoselection as a strategy for organ preservation in advanced oropharynx canc- er: response and survival positively associated with HPV16 copy number[J]. J Clin Oncol, 2008,26(19)~3138-3146. 被引量：1
  • 9任晓勇,罗花南,成颖,靳耀峰,常换换,康全清.喉癌组织中HPV16/18E6、p53和EZH2的表达及其相关性分析[J].临床肿瘤学杂志,2013,18(10):893-897. 被引量：7
  • 10杨波,胡金梅,丁跃明,潘云.HPV16/18、P16蛋白在头颈部鳞状细胞癌中的表达及意义[J].中华临床医师杂志（电子版）,2014,8(15):98-100. 被引量：8

引证文献1

二级引证文献1

循证医学
2015年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部